![Steven Harr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Harr
Gründer bei
SANA BIOTECHNOLOGY, INC.
Vermögen: 30 Mio $ am 31.05.2026
Profil
Steven D. Harr gründete Sana Biotechnology, Inc. und JW Therapeutics (Shanghai) Co., Ltd. Dr. Harr bekleidet die Position des President, Chief Executive Officer & Director bei Sana Biotechnology, Inc. und Treasurer & Director bei X-Body, Inc. Er ist auch im Vorstand von JW Biotechnology (Shanghai) Co. Ltd. und Repertoire Immune Medicines, Inc. In der Vergangenheit hatte er die Position des Research Analysten bei Morgan Stanley & Co. LLC, Chief Financial Officer & Head-Development bei Juno Therapeutics, Inc. und Direktor bei JW Therapeutics (Shanghai) Co., Ltd. Dr. Harr erhielt einen Bachelor-Abschluss vom College of the Holy Cross (Massachusetts) und einen Doktortitel von der The Johns Hopkins University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SANA BIOTECHNOLOGY, INC. 3,46 % | 30.03.2026 | 8.960.751 ( 3,46 % ) | 30 Mio $ | 31.05.2026 |
Aktive Positionen von Steven Harr
| Unternehmen | Position | Beginn |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Gründer | 13.07.2018 |
JW Biotechnology (Shanghai) Co. Ltd. | Direktor/Vorstandsmitglied | - |
X-Body, Inc.
 X-Body, Inc. BiotechnologyHealth Technology Provides biotechnological research services | Direktor/Vorstandsmitglied | - |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Direktor/Vorstandsmitglied | 01.03.2020 |
Cobalt Biomedicine, Inc.
 Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing therapeutic based drugs | Präsident | - |
Ehemalige bekannte Positionen von Steven Harr
| Unternehmen | Position | Ende |
|---|---|---|
| LOXO ONCOLOGY INC | Direktor/Vorstandsmitglied | 15.02.2019 |
JW Therapeutics (Shanghai) Co., Ltd.
 JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Gründer | 25.09.2018 |
| JUNO THERAPEUTICS INC | Finanzdirektor/CFO | 01.03.2018 |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Vorstandsvorsitzender | 01.04.2014 |
| ░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░ | ░░░░░░░░ | - |
Ausbildung von Steven Harr
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
86
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
X-Body, Inc.
X-Body, Inc. BiotechnologyHealth Technology Provides biotechnological research services | Health Technology |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
JW Biotechnology (Shanghai) Co. Ltd. | |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Health Technology |
JW (Cayman) Therapeutics Co. Ltd.
 JW (Cayman) Therapeutics Co. Ltd. BiotechnologyHealth Technology Operates as biotechnology company that develops and manufactures cell immunotherapy products | Health Technology |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
Cobalt Biomedicine, Inc.
Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing therapeutic based drugs | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
